The effect of nicotine induced behavioral sensitization on dopamine D1 receptor pharmacology: An in vivo and ex vivo study in the rat

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Wouter GoutierA C McCreary

Abstract

Behavioral sensitization is a phenomenon which can develop following repeated intermittent administration of a range of psychostimulants, and other compounds, and may model neuroplastic changes seen in addictive processes and neuropsychiatric disease. The aim of the present study was to investigate the effect of dopamine D1 receptor (D1R) ligands on nicotine-induced behavioral sensitization and their molecular consequences in the striatum. Wistar rats were chronically treated (5 days) with vehicle or nicotine (0.4 mg/kg; s.c.) and locomotor activity was measured. Following a 5 day withdrawal period, rats were pretreated with vehicle or the D1R antagonist SCH-23390 (0.03 mg/kg; i.p.) and challenged with nicotine. Either 45 min or 24h post-challenge, the striatum was isolated and ex vivo receptor binding and cAMP accumulation (using LC-MS/MS) were assessed. It was shown that chronic nicotine administration induced the development and expression of locomotor sensitization, of which the latter was blocked by SCH-23390. Nicotine-induced sensitization had no effect on forskolin stimulated cAMP accumulation but increased the efficacy of dopamine for the D1R and decreased the potency of D1R agonists. These effects were antagonized by i...Continue Reading

References

Jan 11, 1979·Nature·J W Kebabian, D B Calne
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·R T FremeauM G Caron
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G Di Chiara, A Imperato
Sep 1, 1993·Brain Research. Brain Research Reviews·T E Robinson, K C Berridge
Apr 20, 2000·European Journal of Pharmacology·G Di Chiara
Jul 6, 2000·Archives of Medical Research·S Mihailescu, R Drucker-Colín
May 23, 2002·The Journal of Pharmacology and Experimental Therapeutics·David M MottolaRichard B Mailman
Nov 28, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jong Y BahkMyeong O Kim
Apr 22, 2004·Pharmacology, Biochemistry, and Behavior·Evangelene DanielaSusan Schenk
Jun 29, 2004·Behavioural Brain Research·Joseph A SchroederEllen M Unterwald
Jul 15, 2004·Pharmacology, Biochemistry, and Behavior·Steven B HarrodRosemarie M Booze
Mar 17, 2007·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Joseph R DiFranza, Robert J Wellman
Feb 27, 2013·Neuroscience and Biobehavioral Reviews·Barry J Everitt, Trevor W Robbins

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.